Adiponectin is a negative regulator of NK cell cytotoxicity

Kun Yong Kim, Jae Kwang Kim, Seung Hyun Han, Jong Seok Lim, Keun Il Kim, Dae Ho Cho, Myeong Sok Lee, Jeong Hyung Lee, Do Young Yoon, Suk Ran Yoon, Jin Woong Chung, Inpyo Choi, Eunjoon Kim, Young Yang

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

NK cells are a key component of innate immune systems, and their activity is regulated by cytokines and hormones. Adiponectin, which is secreted from white adipose tissues, plays important roles in various diseases, including hypertension, cardiovascular diseases, inflammatory disorders, and cancer. In this study the effect of adiponectin on NK cell activity was investigated. Adiponectin was found to suppress the IL-2-enhanced cytotoxic activity of NK cells without affecting basal NK cell cytotoxicity and to inhibit IL-2-induced NF-κB activation via activation of the AMP-activated protein kinase, indicating that it suppresses IL-2-enhanced NK cell cytotoxicity through the AMP-activated protein kinase-mediated inhibition of NF-κB activation. IFN-γ enhances NK cell cytotoxicity by causing an increase in the levels of expression of TRAIL and Fas ligand. The production of IFN-γ, one of the NF-κB target genes in NK cells, was also found to be suppressed by adiponectin, accompanied by the subsequent down-regulation of IFN-γ-inducible TRAIL and Fas ligand expression. These results clearly demonstrate that adiponectin is a potent negative regulator of IL-2-induced NK cell activation and thus may act as an in vivo regulator of anti-inflammatory functions.

Original languageEnglish
Pages (from-to)5958-5964
Number of pages7
JournalJournal of Immunology
Volume176
Issue number10
DOIs
Publication statusPublished - 2006 May 15
Externally publishedYes

Fingerprint

Adiponectin
Natural Killer Cells
Interleukin-2
AMP-Activated Protein Kinases
Fas Ligand Protein
White Adipose Tissue
Immune System
Anti-Inflammatory Agents
Cardiovascular Diseases
Down-Regulation
Hormones
Cytokines
Hypertension
Genes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Kim, K. Y., Kim, J. K., Han, S. H., Lim, J. S., Kim, K. I., Cho, D. H., ... Yang, Y. (2006). Adiponectin is a negative regulator of NK cell cytotoxicity. Journal of Immunology, 176(10), 5958-5964. https://doi.org/10.4049/jimmunol.176.10.5958

Adiponectin is a negative regulator of NK cell cytotoxicity. / Kim, Kun Yong; Kim, Jae Kwang; Han, Seung Hyun; Lim, Jong Seok; Kim, Keun Il; Cho, Dae Ho; Lee, Myeong Sok; Lee, Jeong Hyung; Yoon, Do Young; Yoon, Suk Ran; Chung, Jin Woong; Choi, Inpyo; Kim, Eunjoon; Yang, Young.

In: Journal of Immunology, Vol. 176, No. 10, 15.05.2006, p. 5958-5964.

Research output: Contribution to journalArticle

Kim, KY, Kim, JK, Han, SH, Lim, JS, Kim, KI, Cho, DH, Lee, MS, Lee, JH, Yoon, DY, Yoon, SR, Chung, JW, Choi, I, Kim, E & Yang, Y 2006, 'Adiponectin is a negative regulator of NK cell cytotoxicity', Journal of Immunology, vol. 176, no. 10, pp. 5958-5964. https://doi.org/10.4049/jimmunol.176.10.5958
Kim, Kun Yong ; Kim, Jae Kwang ; Han, Seung Hyun ; Lim, Jong Seok ; Kim, Keun Il ; Cho, Dae Ho ; Lee, Myeong Sok ; Lee, Jeong Hyung ; Yoon, Do Young ; Yoon, Suk Ran ; Chung, Jin Woong ; Choi, Inpyo ; Kim, Eunjoon ; Yang, Young. / Adiponectin is a negative regulator of NK cell cytotoxicity. In: Journal of Immunology. 2006 ; Vol. 176, No. 10. pp. 5958-5964.
@article{7f572df71fe7402ab22b60518367b3f3,
title = "Adiponectin is a negative regulator of NK cell cytotoxicity",
abstract = "NK cells are a key component of innate immune systems, and their activity is regulated by cytokines and hormones. Adiponectin, which is secreted from white adipose tissues, plays important roles in various diseases, including hypertension, cardiovascular diseases, inflammatory disorders, and cancer. In this study the effect of adiponectin on NK cell activity was investigated. Adiponectin was found to suppress the IL-2-enhanced cytotoxic activity of NK cells without affecting basal NK cell cytotoxicity and to inhibit IL-2-induced NF-κB activation via activation of the AMP-activated protein kinase, indicating that it suppresses IL-2-enhanced NK cell cytotoxicity through the AMP-activated protein kinase-mediated inhibition of NF-κB activation. IFN-γ enhances NK cell cytotoxicity by causing an increase in the levels of expression of TRAIL and Fas ligand. The production of IFN-γ, one of the NF-κB target genes in NK cells, was also found to be suppressed by adiponectin, accompanied by the subsequent down-regulation of IFN-γ-inducible TRAIL and Fas ligand expression. These results clearly demonstrate that adiponectin is a potent negative regulator of IL-2-induced NK cell activation and thus may act as an in vivo regulator of anti-inflammatory functions.",
author = "Kim, {Kun Yong} and Kim, {Jae Kwang} and Han, {Seung Hyun} and Lim, {Jong Seok} and Kim, {Keun Il} and Cho, {Dae Ho} and Lee, {Myeong Sok} and Lee, {Jeong Hyung} and Yoon, {Do Young} and Yoon, {Suk Ran} and Chung, {Jin Woong} and Inpyo Choi and Eunjoon Kim and Young Yang",
year = "2006",
month = "5",
day = "15",
doi = "10.4049/jimmunol.176.10.5958",
language = "English",
volume = "176",
pages = "5958--5964",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Adiponectin is a negative regulator of NK cell cytotoxicity

AU - Kim, Kun Yong

AU - Kim, Jae Kwang

AU - Han, Seung Hyun

AU - Lim, Jong Seok

AU - Kim, Keun Il

AU - Cho, Dae Ho

AU - Lee, Myeong Sok

AU - Lee, Jeong Hyung

AU - Yoon, Do Young

AU - Yoon, Suk Ran

AU - Chung, Jin Woong

AU - Choi, Inpyo

AU - Kim, Eunjoon

AU - Yang, Young

PY - 2006/5/15

Y1 - 2006/5/15

N2 - NK cells are a key component of innate immune systems, and their activity is regulated by cytokines and hormones. Adiponectin, which is secreted from white adipose tissues, plays important roles in various diseases, including hypertension, cardiovascular diseases, inflammatory disorders, and cancer. In this study the effect of adiponectin on NK cell activity was investigated. Adiponectin was found to suppress the IL-2-enhanced cytotoxic activity of NK cells without affecting basal NK cell cytotoxicity and to inhibit IL-2-induced NF-κB activation via activation of the AMP-activated protein kinase, indicating that it suppresses IL-2-enhanced NK cell cytotoxicity through the AMP-activated protein kinase-mediated inhibition of NF-κB activation. IFN-γ enhances NK cell cytotoxicity by causing an increase in the levels of expression of TRAIL and Fas ligand. The production of IFN-γ, one of the NF-κB target genes in NK cells, was also found to be suppressed by adiponectin, accompanied by the subsequent down-regulation of IFN-γ-inducible TRAIL and Fas ligand expression. These results clearly demonstrate that adiponectin is a potent negative regulator of IL-2-induced NK cell activation and thus may act as an in vivo regulator of anti-inflammatory functions.

AB - NK cells are a key component of innate immune systems, and their activity is regulated by cytokines and hormones. Adiponectin, which is secreted from white adipose tissues, plays important roles in various diseases, including hypertension, cardiovascular diseases, inflammatory disorders, and cancer. In this study the effect of adiponectin on NK cell activity was investigated. Adiponectin was found to suppress the IL-2-enhanced cytotoxic activity of NK cells without affecting basal NK cell cytotoxicity and to inhibit IL-2-induced NF-κB activation via activation of the AMP-activated protein kinase, indicating that it suppresses IL-2-enhanced NK cell cytotoxicity through the AMP-activated protein kinase-mediated inhibition of NF-κB activation. IFN-γ enhances NK cell cytotoxicity by causing an increase in the levels of expression of TRAIL and Fas ligand. The production of IFN-γ, one of the NF-κB target genes in NK cells, was also found to be suppressed by adiponectin, accompanied by the subsequent down-regulation of IFN-γ-inducible TRAIL and Fas ligand expression. These results clearly demonstrate that adiponectin is a potent negative regulator of IL-2-induced NK cell activation and thus may act as an in vivo regulator of anti-inflammatory functions.

UR - http://www.scopus.com/inward/record.url?scp=33646470282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646470282&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.176.10.5958

DO - 10.4049/jimmunol.176.10.5958

M3 - Article

C2 - 16670304

AN - SCOPUS:33646470282

VL - 176

SP - 5958

EP - 5964

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -